Steven P. Coen - 07 Mar 2024 Form 4 Insider Report for Ginkgo Bioworks Holdings, Inc. (DNA)

Signature
/s/ Karen Tepichin, Attorney-in-Fact
Issuer symbol
DNA
Transactions as of
07 Mar 2024
Net transactions value
$0
Form type
4
Filing time
08 Mar 2024, 16:56:29 UTC
Previous filing
28 Jul 2023
Next filing
06 May 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DNA Restricted Stock Units Award +300,000 300,000 07 Mar 2024 Class A Common Stock 300,000 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F2 The RSUs vest as follows: 2/48ths of the underlying shares on May 1, 2024, then 46 equal monthly installments thereafter.

Remarks:

Chief Accounting Officer